Tyra Biosciences Inc (TYRA)
Healthcare
Biotechnology
31.90 $
-3.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Tyra Biosciences Inc (TYRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -95 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -2.6 | -7.8 | -24 | -50 | -50 | -70 | -95 | |
| 0.0 | 0.0 | 0.1 | 0.3 | 0.4 | 0.5 | 0.5 | |
| 0.0 | 0.4 | 2.9 | 11 | 14 | 23 | 28 | |
| 0.9 | 0.5 | 2.9 | 11 | – | – | – | |
| 0.5 | 1.1 | -0.5 | -5.8 | 6.4 | -0.7 | -1.6 | |
| 0.0 | 0.3 | 0.7 | 0.6 | 0.8 | 0.7 | 0.1 | |
| 0.0 | -0.3 | -0.6 | -0.6 | -145 | -98 | 72 | |
| – | – | 311 | – | 0.0 | -0.4 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 0.2 | 23 | 311 | 0.6 | 1.5 | 202 | 8.1 | |
| -2.5 | 15 | 287 | -51 | -193 | 34 | -15 | |
| -2.6 | -8.1 | -24 | -51 | -51 | -70 | -95 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.